CRISPR Therapeutics AG. Daily Stock Analysis

Daily Stock Analysis, CRSP, CRISPR Therapeutics AG, priceseries

CRISPR Therapeutics AG. Daily Stock Analysis
Stock Information
Open
54.15
Close
55.20
High
56.84
Low
53.70
Previous Close
53.19
Daily Price Gain
2.01
YTD High
79.40
YTD High Date
Jan 3, 2022
YTD Low
50.54
YTD Low Date
Feb 24, 2022
YTD Price Change
-24.04
YTD Gain
-30.34%
52 Week High
169.76
52 Week High Date
Jun 30, 2021
52 Week Low
50.54
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-58.42
52 Week Gain
-51.42%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 24. 2017
17.90
Mar 10. 2017
21.15
10 Trading Days
18.17%
Link
LONG
Jun 21. 2017
15.04
Jun 29. 2017
15.83
6 Trading Days
5.24%
Link
LONG
Dec 21. 2017
19.58
Feb 1. 2018
36.51
27 Trading Days
86.45%
Link
LONG
May 10. 2018
52.12
May 31. 2018
63.49
14 Trading Days
21.82%
Link
LONG
Jan 4. 2019
30.27
Jan 22. 2019
32.54
11 Trading Days
7.50%
Link
LONG
Jun 27. 2019
45.36
Aug 2. 2019
49.40
25 Trading Days
8.90%
Link
LONG
Oct 23. 2019
39.23
Dec 9. 2019
69.08
32 Trading Days
76.08%
Link
LONG
Apr 8. 2020
44.38
Apr 29. 2020
50.21
14 Trading Days
13.13%
Link
LONG
May 5. 2020
52.00
May 27. 2020
62.29
15 Trading Days
19.79%
Link
LONG
Jul 1. 2020
78.50
Jul 23. 2020
89.11
15 Trading Days
13.52%
Link
LONG
Oct 5. 2020
86.75
Oct 21. 2020
91.27
12 Trading Days
5.21%
Link
LONG
Nov 12. 2020
101.77
Dec 29. 2020
155.21
31 Trading Days
52.51%
Link
LONG
Jan 6. 2021
163.85
Jan 20. 2021
191.22
9 Trading Days
16.70%
Link
LONG
May 17. 2021
109.22
Jun 1. 2021
115.81
10 Trading Days
6.03%
Link
LONG
Jun 22. 2021
129.20
Jul 7. 2021
144.05
10 Trading Days
11.50%
Link
Company Information
Stock Symbol
CRSP
Exchange
NasdaqGM
Company URL
http://www.crisprtx.com
Company Phone
6173154600
CEO
Rodger Novak
Headquarters
-
Business Address
BAARERSTRASSE 14, ZUG, SWITZERLAND CH-6300
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001674416
About

CRISPR Therapeutics AG develops gene-based medicines for patients with serious diseases. Its therapeutic molecular level using the breakthrough genome-editing technology called CRISPR-Cas9. The company was founded by Rodger Novak, Emmanuelle Charpentier and Shaun Patrick Foy in 2014 and is headquartered in Basel, Switzerland.

Description

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading